Your browser doesn't support javascript.
loading
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.
Backen, Alison; Renehan, Andrew G; Clamp, Andrew R; Berzuini, Carlo; Zhou, Cong; Oza, Amit; Bannoo, Selina; Scherer, Stefan J; Banks, Rosamonde E; Dive, Caroline; Jayson, Gordon C.
Afiliación
  • Backen A; Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom.
  • Renehan AG; Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Center, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, M20 4BX, UK.
  • Clamp AR; Dept Medical Oncology, University of Manchester and Christie Hospital, Wilmslow Road, Withington, Manchester M20 4BX, UK.
  • Berzuini C; Center for Biostatistics, Institute of Population Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
  • Zhou C; Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom.
  • Oza A; Bras Family Drug Development Program, Princess Margaret Hospital, 610 University Avenue, Toronto M5G 2M9.
  • Bannoo S; MRC Clinical Trials Unit, Aviation House, 125 Kingsway, London WC2B 6NH.
  • Scherer SJ; Biocartis SA, EPFL-Quartier de l'Innovation, Bâtimont G, CH-1015 Lausanne.
  • Banks RE; Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds LS9 7TF, UK.
  • Dive C; Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom.
  • Jayson GC; Translational Angiogenesis Group, University of Manchester and Christie Hospital, Wilmslow Road, Withington, Manchester, M20 4BX, UK.
Clin Cancer Res ; 20(17): 4549-4558, 2014 Sep 01.
Article en En | MEDLINE | ID: mdl-24947924
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Receptor TIE-2 / Angiopoyetina 1 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Receptor TIE-2 / Angiopoyetina 1 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido